WZ4002

Catalog No. A10991

WZ4002是一种新型的，突变选择性EGFR抑制剂，作用于EGFR(L858R)/(T790M)，在BaF3细胞系中IC50为2 nM/8 nM；对ERBB2磷酸化(T798I)没有抑制作用。

Technical details

Catalog Num	A10991
M. Wt	495.0
Formula	C25H27ClN6O3
Purity	>98%
Storage	at -20°C 3 years Powder
CAS No.	1213269-23-8
Synonyms
SMILES	CN1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)OC4=CC=CC(=C4)NC(=O)C=C)Cl)OC

Biological Activity

WZ4002是一种新型的，突变选择性EGFR抑制剂，作用于EGFR(L858R)/(T790M)，在BaF3细胞系中IC50为2 nM/8 nM；对ERBB2磷酸化(T798I)没有抑制作用。

Targets

EGFR (L858R) (BaF3 cells)	EGFR (L858R/T790M) (BaF3 cells)
2 nM	8 nM

Solubility *

In vitro (25°C)	DMSO	12 mg/mL (24.28 mM)
	Water	Insoluble
	Ethanol	Insoluble
In vivo	30% PEG400+0.5% Tween80+5% propylene glycol	28 mg/mL
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Preparing Stock Solutions

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
0.1 mM	20.2 mL	101.01 mL	202.02 mL
0.5 mM	4.04 mL	20.2 mL	40.4 mL
1 mM	2.02 mL	10.1 mL	20.2 mL
5 mM	0.4 mL	2.02 mL	4.04 mL

*The above data is based on the productmolecular weight 495.0. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.